| Molecular Imaging Market Size – USD 28.02 Billion in 2021, Market Growth – at a CAGR of 4.9%, Market Trends – Rising prevalence of various chronic diseases such as cancer and other genetic diseases, rising geriatric population, and technological advancements in the healthcare sector are the key factors behind the revenue growth of the market. |
The global molecular imaging market is projected to be worth USD 10.71 Billion by 2027, according to a current analysis by Emergen Research. The molecular imaging market is observing a rapid growth attributed to the rising occurrence of chronic diseases like cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.
Get Free Sample PDF Brochure @ https://www.emergenresearch.com/request-sample/271
The report also discusses the key players involved in the market as well as new entrants in the market. It focuses on the recent mergers & acquisitions, joint ventures, collaborations, partnerships, licensing agreements, brand promotions, and product launches, among others. The report also provides details about the company overview, business expansion plans, product portfolio, manufacturing and production capacity, global market position, financial status, and consumer base.
Leading Players Profiled in the Report:
Canon Inc., Digirad Corporation, General Electric Company, PerkinElmer Inc., Siemens Healthineers Inc., Bruker Corporation, Cardinal Health, Thermo Fisher Scientific, Advanced Accelerator Applications, DDD-Diagnostics A/S
The report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of the key companies involved in the market. The report provides valuable insights to the stakeholders, investors, product managers, marketing executives, and other industry professionals.
Molecular Imaging Market Segmentation:
Product Type Outlook (Revenue, USD Billion; 2017-2027)
Positron Emission Tomography
Single Photon Emission Computed Tomography
Magnetic Resonance Imaging
Computed Tomography
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Cardiovascular Diseases
Neurology
Respiratory Diseases
Others
End-Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Ambulatory Surgical Centers
Diagnostic Centers
To know more about the report @ https://www.emergenresearch.com/industry-report/molecular-imaging-market
The competitive analysis also includes regional analysis of major geographical regions. The report covers regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report also offers a country wise analysis to impart better understanding of the global Molecular Imaging market with regards to market share, market size, production and consumption ratio, product launches and R&D activities, investment opportunities, and presence of key players in the region.
Key Features of the Molecular Imaging Market Report:
The report offers details about key drivers, restraints, opportunities, challenges, growth prospects, limitations, and threats
The report encompasses details about the key companies, product portfolio along with specifications, production valuation, and market shares
Evaluation of key current and emerging market trends and growth prospects
It also offers research-backed estimations for the forecast period of eight years, primarily to estimate the potential market growth
Brief overview of industry with regards to research and development, technological advancements, and product development
In-depth assessment of upstream raw materials, downstream buyers, demands, and current market scenario
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/271
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
Look Over transcripts provided by Emergen Research
Take a Look at OUR Reports:
Cloud Backup & Recovery Market @ https://www.emergenresearch.com/industry-report/cloud-backup-recovery-market
Automotive LiDAR Market @ https://www.emergenresearch.com/industry-report/automotive-lidar-market
Automatic Number Plate Recognition (ANPR) System Market @ https://www.emergenresearch.com/industry-report/automatic-number-plate-recognition-system-market
3D Printing Materials Market @ https://www.emergenresearch.com/industry-report/3d-printing-materials-market
Greenhouse Film Market @ https://www.emergenresearch.com/industry-report/greenhouse-film-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Molecular Imaging Market Outlook to 2025
Molecular imaging is an emerging technology that is gaining importance in the healthcare sector for a variety of applications. This technology provides a way to visualize and measure the internal components of complex systems like cells and tissues. Molecular imaging is accordingly gaining prominence as a tool in many medical fields to diagnose and track a host of diseases, enabling researchers and physicians to make informed decisions.
The molecular imaging market is projected to reach US$ 28.77 Bn by 2025 and is expected to rise at a significant CAGR of 9.7% during the forecast period 2019-2025. The non-invasive nature associated with molecular imaging, which results in lesser pain has made it a popular medical imagining technique. This is the primary driver of the global molecular imaging market. Additionally, the rapidly increasing prevalence of chronic diseases and the growing demand for targeted drug delivery are further driving the growth of this market.
The technology break-down of the market is divided into single-photon emission computed tomography (SPECT), positron emission tomography (PET), hybrid imaging, and optical imaging. The SPECT & PET segment is projected to witness lucrative growth due to the increasing prevalence of chronic diseases, rising support from government organizations, and growing demand for targeted drug delivery.
Furthermore, geographic break-down of the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to be the largest revenue contributor during the forecast period, followed by Europe & Asia Pacific. This can be attributed to the expanding base of healthcare infrastructure in North America and Europe and the increasing outcomes supported by cutting-edge molecular imaging technologies. Additionally, epigenetic imaging and the expansion of molecular imaging in personalized medicine are anticipated to create potential opportunities for the molecular imaging market players.
Currently, some of the major players operating in the molecular imaging market include GE Healthcare, Siemens AG, Toshiba Medical Systems Corporation, Canon Medical Systems Corporation, Philips Healthcare, Hitachi Medical Corporation, and Visia Imaging Systems. Moreover, these market players are focusing on improving the scope of their services and introducing innovative imaging technologies. They are also engaged in collaborations with organizations and other industry players to explore new opportunities in the market.
Overall, the increasing prevalence of chronic diseases, technological advancements in the field of imaging, and government initiatives are expected to drive the growth of the molecular imaging market. The market players are leveraging on the latest advances to develop advanced imaging solutions and products. In addition, strategic partnerships, collaborations, and different technological advancements are likely to present lucrative opportunities for market participants moving ahead.
Recent Comments